BrightSpec
Latest round
- Series C
Last raised
- Dec 2022
Total raised
- $9.5M
Investors
- 6
About BrightSpec
Based in Virginia, US, and founded in 2012 by co-founders Dave McDaniel, Justin Neill, Matt Muckle, and Brooks Pate, BrightSpec, Inc. operates as a life science tools company that offers a complete line of spectrometers for broadband identification of unknowns to targeted validation or impurity analysis. In December 2022, BrightSpec, Inc. Colsman. BrightSpec, Inc. product offering includes targeted instruments for screening and quantitation of known components in a mixture; broadband Instruments for comprehensive sample profiling and characterization of molecular structures including unknowns; research and education instruments specific to particular fundamental research needs as well as for the classroom; custom Instruments in several designs; GC-MRR serve as an extraordinarily-selective detector for Gas Chromatography. In addition, the company offers comprehensive lab services utilizing the capabilities of MRR.
Who invested in BrightSpec
6 investors across 2 rounds
See all investors in BrightSpec
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about BrightSpec
Who invested in BrightSpec?
BrightSpec has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has BrightSpec raised?
BrightSpec has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did BrightSpec last raise money?
BrightSpec's most recent round on record is a Series C, in Dec 2022.
What does BrightSpec do?
Based in Virginia, US, and founded in 2012 by co-founders Dave McDaniel, Justin Neill, Matt Muckle, and Brooks Pate, BrightSpec, Inc.
Where is BrightSpec headquartered?
BrightSpec is headquartered in Charlottesville, US.
Which VCs invest in companies like BrightSpec?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at BrightSpec's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like BrightSpec? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.